ACE-Inhibitor Related Angioedema Is Not Sufficiently Reported to the Danish Adverse Drug Reactions Database

References

• Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200–1205. doi:10.1001/jama.279.15.12009555760
   PubMed Web of Science ®Google Scholar
• Wester K, Jonsson A, Spigset O, Hagg S. Spontaneously reported fatal suspected adverse drug reactions: a 10-year survey from Sweden. Pharmacoepidemiol Drug Saf. 2007;16(2):173–180. doi:10.1002/pds.126316739241
   PubMed Web of Science ®Google Scholar
• Bangsgaard N, Saunte DM, Folkenberg M, Zachariae C. Serious adverse events reporting on systemic terbinafine: a Danish register-based study. Acta Derm Venereol. 2011;91(3):358–359. doi:10.2340/00015555-104121290086
   PubMed Web of Science ®Google Scholar
• Seruga B, Templeton AJ, Badillo FEV, Ocana A, Amir E, Tannock IF. Under-reporting of harm in clinical trials. Lancet Oncol. 2016;17(5):e209–e219. doi:10.1016/S1470-2045(16)00152-227301048
   PubMed Web of Science ®Google Scholar
• Backstrom M, Mjorndal T, Dahlqvist R. Under-reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf. 2004;13(7):483–487. doi:10.1002/pds.96215269932
   PubMed Web of Science ®Google Scholar
• Belton KJ. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group. Eur J Clin Pharmacol. 1997;52(6):423–427. doi:10.1007/s0022800503149342576
   PubMed Web of Science ®Google Scholar
• Hasford J, Goettler M, Munter K-H, Muller-Oerlinghausen B. Physicians’ knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol. 2002;55(9):945–950. doi:10.1016/S0895-4356(02)00450-X12393084
   PubMed Web of Science ®Google Scholar
• Gahr M, Eller J, Connemann BJ, Schonfeldt-Lecuona C. Subjective reasons for non-reporting of adverse drug reactions in a sample of physicians in outpatient care. Pharmacopsychiatry. 2016;49(2):57–61. doi:10.1055/s-0035-156929126744100
   PubMed Web of Science ®Google Scholar
• Hidalgo-Simon A, Arlett P. The pharmacovigilance legislation. Eur Med Agency. 2012;5(5):485–488. doi:10.1586/ecp.12.46
   Web of Science ®Google Scholar
• The Danish Health Authority. Bekendtgørelse om indberetning af bivirkninger ved lægemidler m.m; 2014 Available from: https://www.retsinformation.dk/Forms/R0710.aspx?id=162794. Accessed 82, 2017.
   Google Scholar
• National Institutes of Health. DailyMed; 2017 Available from: https://dailymed.nlm.nih.gov/dailymed/. Accessed 728, 2017.
   Google Scholar
• Holm JPY, Ovesen T. Increasing rate of angiotensin-converting enzyme inhibitor-related upper airway angio-oedema. Dan Med J. 2009;59(6):A4449.
   Google Scholar
• Rasmussen ER, Buchwald V, Wadelius M, et al. Assessment of 105 patients with angiotensin converting enzyme-inhibitor induced angioedema. Int J Otolaryngol. 2017;2017:1–7. doi:10.1155/2017/1476402.
   Google Scholar
• Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf. 2001;24(8):599–606. doi:10.2165/00002018-200124080-0000411480492
   PubMed Web of Science ®Google Scholar
• Jaiganesh T, Wiese M, Hollingsworth J, et al. Acute angioedema: recognition and management in the emergency department. Eur J Emerg Med. 2013;20(1):10–17. doi:10.1097/MEJ.0b013e328356f76e22976464
   PubMed Web of Science ®Google Scholar
• Rasmussen ER, Mey K, Bygum A. Angiotensin-converting enzyme inhibitor-induced angioedema–a dangerous new epidemic. Acta Derm Venereol. 2014;94(3):260–264. doi:10.2340/00015555-176024285044
   PubMed Web of Science ®Google Scholar
• Sánchez-Borges M, González-Aveledo LA. Angiotensin-converting enzyme inhibitors and angioedema. Allergy Asthma Immunol Res. 2010;2(3):195–198. doi:10.4168/aair.2010.2.3.19520592919
   PubMed Web of Science ®Google Scholar
• Holm JPY, Ovesen T. Increasing rate of angiotensin-converting enzyme inhibitor-related upper airway angio-oedema. Dan Med J. 2012;59(6):A4449.22677247
   PubMed Web of Science ®Google Scholar
• Tai S, Mascaro M, Goldstein NA. Angioedema: a review of 367 episodes presenting to three tertiary care hospitals. Ann Otol Rhinol Laryngol. 2010;119(12):836–841. doi:10.1177/00034894101190120821250556
   PubMed Web of Science ®Google Scholar
• Scott SI, Andersen MF, Aagaard L, Buchwald CV, Rasmussen ER. Dipeptidyl peptidase-4 inhibitor induced angioedema – an overlooked adverse drug reaction? Curr Diabetes Rev. 2017. doi:10.2174/15733998136661702141138
   Web of Science ®Google Scholar
• Agostoni A, Cicardi M, Cugno M, Zingale LC, Gioffré D, Nussberger J. Angioedema due to angiotensin-converting enzyme inhibitors. Immunopharmacology. 1999;44(1):21–25. doi:10.1016/S0162-3109(99)00107-110604520
   PubMed Web of Science ®Google Scholar
• Bernstein JA, Cremonesi P, Hoffmann TK, Hollingsworth J. Angioedema in the emergency department: a practical guide to differential diagnosis and management. Int J Emerg Med. 2017;10(1):15. doi:10.1186/s12245-017-0141-z28405953
   PubMedGoogle Scholar
• Stone CJ, Brown NJ. Angiotensin-converting enzyme inhibitor and other drug-associated angioedema. Immunol Allergy Clin North Am. 2017;37(3):483–495. doi:10.1016/j.iac.2017.04.00628687104
   PubMed Web of Science ®Google Scholar
• Initiative S. STROBE statement—checklist of items that should be included in reports of cohort studies. Available from: https://www.strobe-statement.org/fileadmin/Strobe/uploads/checklists/STROBE_checklist_v4_cohort.pdf. Accessed 52, 2018.
   Google Scholar
• University of Dundee. Prediction-ADR; 2017 Available from: https://sites.dundee.ac.uk/prediction-adr/. Accessed 12 10, 2019.
   Google Scholar
• Danish Medicines Agency. Report side effects in humans from medicines and vaccines; 2017 Available from: https://laegemiddelstyrelsen.dk/en/sideeffects/side-effects-from-medicines/report-a-side-effect/~/link.aspx?_id=6B84AE2577A04EB29B0A47F444BD6548&_z=z. Accessed 1024, 2017.
   Google Scholar
• Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39(7 Suppl):22–25. doi:10.1177/140349481038796521775345
   PubMed Web of Science ®Google Scholar
• Schmidt M, Hallas J, Laursen M, Friis S. Data resource profile: Danish online drug use statistics (MEDSTAT). Int J Epidemiol. 2016;45(5):1401–1402g. doi:10.1093/ije/dyw11627892409
   PubMed Web of Science ®Google Scholar
• The Danish Health Data Authority. Statistics on the total sales of medicines in Denmark 1996–2015; 2016 Available from: http://medstat.dk/en. Accessed 1230, 2017.
   Google Scholar
• Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377–381. doi:10.1016/j.jbi.2008.08.010
   PubMed Web of Science ®Google Scholar
• Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385–396. doi:10.2165/00002018-200629050-0000316689555
   PubMed Web of Science ®Google Scholar
• Central Intelligence Agency. East & Southeast Asia: Thailand; 2017 Available from: https://www.cia.gov/library/publications/the-world-factbook/geos/th.html. Accessed 1210, 2017.
   Google Scholar
• Win TSZ, Chaiyakunapruk N, Suwankesawong W, Dilokthornsakul P, Nathisuwan S. Renin angiotensin system blockers-associated angioedema in the Thai population: analysis from Thai National Pharmacovigilance Database. Asian Pac J Allergy Immunol. 2015;33(3):227–235. doi:10.12932/AP0556.33.3.201526342120
   PubMed Web of Science ®Google Scholar
• Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32(1):19–31. doi:10.2165/00002018-200932010-0000219132802
   PubMed Web of Science ®Google Scholar
• Wakefield YS, Theaker ED, Pemberton MN. Angiotensin converting enzyme inhibitors and delayed onset, recurrent angioedema of the head and neck. Br Dent J. 2008;205(10):553–556. doi:10.1038/sj.bdj.2008.98219023310
   PubMed Web of Science ®Google Scholar
• Lopez-Gonzalez E, Herdeiro MT, Pineiro-Lamas M, Figueiras A. Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial. Drug Saf. 2014;38(2):189–196. doi:10.1007/s40264-014-0256-6
   Web of Science ®Google Scholar
• Vinther S, Klarskov P, Borgeskov H, et al. An adverse drug event manager facilitates spontaneous reporting of adverse drug reactions. Dan Med J. 2017;64(1).
   Web of Science ®Google Scholar
• Town GI, Hallwright GP, Maling TJ, O’Donnell TV. Angiotensin converting enzyme inhibitors and cough. N Z Med J. 1987;100(820):161–163.2837699
   PubMed Web of Science ®Google Scholar
• Montoro de Francisco A, Garcia-Luque A, Fernandez M, Puerro M. Side effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: are we facing a new syndrome. Am J Cardiol. 2012;110(10):1552–1553. doi:10.1016/j.amjcard.2012.08.02723102232
   PubMed Web of Science ®Google Scholar